|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 701 Pennsylvania Ave., NW Suite 720 |
Address2 |
|
| City | WASHINGTON |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 5632-12
|
||||||||
|
6. House ID# 312570000
|
||||||||
| TYPE OF REPORT | 8. Year | 2014 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Brian McCullough |
Date | 7/21/2014 9:33:09 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
Monitor legislative and administrative action related to pollinator health and habitat promotion.
S. 954, Agriculture Reform, Food, and Jobs Act of 2013.
Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Winter Wheat Cereals Project and Pollinators.
H.R. 2642, Federal Agriculture Reform and Risk Management Act 2013 (P.L. 113-79).
H.R. 1947, Federal Agriculture Reform and Risk Management Act of 2013. Provisions related to National Pollutant Elimination System (NPDES) permits, Endangered Species, Winter Wheat Cereals Project and Pollinators.
S. 809, Genetically Engineered Food Right-to-Know Act. Provisions related to labeling.
S. 1256, Preventing Antibiotic Resistance Act of 2013.
H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill.
H.R. 4432, Safe and Accurate Food Labeling Act of 2014. Provisions related to pollinator issues.
H.R. 2692, Saving America's Pollinators Act of 2013.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Environmental Protection Agency (EPA), Agriculture - Dept of (USDA), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Jean |
Reimers |
|
|
|
Matthew |
Perin |
|
|
|
Donna |
Stephens |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BAN
16. Specific lobbying issues
S. 1106, Sensible Accounting to Value Energy Act of 2013.
All provisions pertaining to sensible accounting to value energy related to mortgages means tested by energy effeciency.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Julie |
Van Egmond |
|
|
|
Dakotah |
Smith |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CHM
16. Specific lobbying issues
Monitor legislative and administrative action on chemical facilities regulation.
Monitor legislative and administrative action related to the Toxic Substances Control Act.
S. 696, Safe Chemicals Act of 2013. Provisions pertaining to chemical risk management.
S. 1009, Chemical Safety Improvement Act. Provisions pertaining to chemical risk management.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Julie |
Van Egmond |
|
|
|
Dakotah |
Smith |
|
|
|
Matthew |
Perin |
|
|
|
Jean |
Reimers |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENG
16. Specific lobbying issues
Monitor legislative and administrative action related to commercial building energy efficiency and building materials technology.
S. 761, Energy Savings and Industrial Competitiveness Act of 2013. All measures related to energy efficiency.
S. 1020, All-Of-The-Above Federal Building Energy Conservation Act of 2013. All measures pertaining to requirements to eliminate fossil fuels by 2030.
S. 1392, Energy Savings and Industrial Competitiveness Act of 2013.
S. 2074, Energy Savings and Industrial Competitiveness Act of 2014.
S. 2262, Energy Savings and Industrial Competitiveness Act of 2014.
All provisions pertaining to the Shaheen Portman Act (S. 761) regarding grants to federal facilities wishing to improve energy efficiency and to update the national model building standards.
H.R. 1616, Energy Savings and Industrial Competitiveness Act of 2013. All provisions pertaining to the Shaheen Portman Act (S. 761) regarding grants to federal facilities wishing to improve energy efficiency and to update the national model building standards.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Julie |
Van Egmond |
|
|
|
Dakotah |
Smith |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Monitor legislative and administrative action related to health care policy.
Monitor legislative and administrative action related to drug user fees.
Monitor legislative and administrative action related to sustainable growth rate and SGR repeal. Issues of tranparency on the CMS preventative maintenance directive for medical equipment.
Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment.
Monitor legislative and administrative action related to drug safety and drug counterfeiting (track and trace).
Monitor legislative and administrative action related to drug importation, drug shortages, authorized genetics, and prescription drug advertising.
Monitor legislative and administrative action related to the 340B Drug Pricing Program.
Monitor legislative and administrative action related to federal preemption for prescription drugs. H.R. 1150, Preservation of Antibiotics for Medical Treatment Act of 2013. Title II and general provisions in the bill.
H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013.
HR 3204, Drug Quality and Security Act. Provisions related to drug distribution.
H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213. S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution.
S. 1256, Preventing Antibiotic Resistance Act of 2013.
S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013.
H.R. 1528, Veterinary Medicine Mobility Act of 2014.
H.R. 4771, Designer Anabolic Steroid Control Act of 2014.
S. 2012, Designer Anabolic Steroid Control Act of 2014.
Monitor the implementation of the Patient Protection and Affordable Care Act, P.L. 111-148.
H.R. 1295, Medical Device Tax Elimination Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Donna |
Stephens |
|
|
|
Julie |
Corcoran |
|
|
|
Thomas |
Lilburn |
|
|
|
Donna |
Stephens |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Monitor legislative and administrative action related to sustainable growth rate and SGR repeal. Issues of tranparency on the CMS preventative maintenance directive for medical equipment. Monitor legislative and administrative action related to Medicare's 2011 guidance on servicing hospital equipment, including medical imaging equipment.
Monitor legislative and administrative action related to Medicare payment for diabetes testing strips, drug rebates for Medicare Part D, and the Independent Payment Advisory Board (IPAB).
S. 1871, SGR Repeal and Medicare Beneficiary Access Act of 2013.
HR 3204, Drug Quality and Security Act. Provisions related to drug distribution.
H.R. 4302, Protecting Access to Medicare Act. Provisions related to imaging and Sec. 213.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Thomas |
Lilburn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
HR 3204, Drug Quality and Security Act. Provisions related to drug distribution.
S. 959, Pharmaceutical Quality, Security, and Accountability Act. Provisions related to drug distribution.
Monitored legislative and federal activity related to drug distribution and safety and pharmacy drug compounding.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Thomas |
Lilburn |
|
|
|
Jean |
Reimers |
|
|
|
Donna |
Stephens |
|
|
|
Matthew |
Perin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAR
16. Specific lobbying issues
Monitor legislative and administrative action related to micellaneous tariff legislation.
H.R. 2708, To amend the Harmonized Tariff Schedule of the United States to modify temporarily certain rates of duty, and for other purposes. Provisions related to specific tariffs.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Jean |
Reimers |
|
|
|
Matthew |
Perin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Monitor legislative and federal activity related to the corporate R&D tax and renewal of tax credits 25C, 179C, and 45L tax credits on energy efficiency.
Draft, Senate tax extender legislation.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Julie |
Van Egmond |
|
|
|
Dakotah |
Smith |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
Monitor legislative and administrative action related to intellectual property protection.
H.R. 3309, the Innovation Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Julie |
Corcoran |
|
|
|
Thomas |
Lilburn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
Monitor legislative and administrative action related to trade promotion authority negotiations.
Monitor legislative and administrative action related to Trans-Pacific Partnerships.
Monitor legislative and administrative action related to Transatlantic Trade and Investment Partnership.
Monitor legislative issues and administrative action related to Trade and Miscellaneous Trade.
Monitor Trade Promotion Authority.
S. 1900, Bipartisan Congressional Trade Priorities Act of 2014.
H.R. 3830, Bipartisan Congressional Trade Priorities Act of 2014.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, U.S. Trade Representative (USTR), State - Dept of (DOS), Commerce - Dept of (DOC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Donna |
Stephens |
|
|
|
Julie |
Corcoran |
|
|
|
Jean |
Reimers |
|
|
|
Matthew |
Perin |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Monitor legislative and administrative action on appropriations and budget.
Draft, House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015.
Draft, Senate Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015. Draft, House Energy and Water Development and Related Agencies Appropriations Act, 2015.
Draft, Senate Energy and Water Development and Related Agencies Appropriations Act, 2015. Draft, House Interior and Environment Appropriations Act, 2015.
Draft, Senate Interior and Environment Appropriations Act, 2015.
Draft, House Departments of Labor, Health and Human Services and Related Agencies Appropriations Act, 2015.
Draft, Senate Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015.
Draft, House National Defense Authorization Act, 2015.
Draft, Senate National Defense Authorization Act, 2015.
Monitor the passage of FY2014 omnibus appropriations legislation (P.L. 113-76). H.R. 2217, Department of Homeland Security Appropriations Act, 2014. Funding for national biodefense and agriculture funding.
H.R. 2725, Food and Drug Administration Safety Over Sequestration Act of 2013.
H.R. 2217, Department of Homeland Security Appropriations Act, 2014. Funding for national biodefense and agriculture funding.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Donna |
Stephens |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENV
16. Specific lobbying issues
Monitor legislative and administrative action on chemical facilities regulation.
Monitor legislative and administrative action related to the Toxic Substances Control Act.
Monitor legislative issues and bills on Superfund.
H.R. 3080, Water Resources Reform and Development Act of 2013.
S. 601, Water Resources Development Act of 2013.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Christopher |
Leahy |
|
|
|
Julie |
Van Egmond |
|
|
|
Dakotah |
Smith |
|
|
|
Matthew |
Perin |
|
|
|
Jean |
Reimers |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address | |
||||||
| City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
| City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |